Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | — | — |
accidentally administered Bexsero instead of MenQuadfi; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. Co-suspect products included Meningococcal vaccine A/C/Y/W conj (tet tox) (Menquadfi) for prophylaxis. On 31-JAN-2025, the patient received the 1st dose of Bexsero. On an unknown date, the patient received Menquadfi. On 31-JAN-2025, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: accidentally administered Bexsero instead of MenQuadfi). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 21-FEB-2025 Other HCP they accidentally administered Bexsero instead of MenQuadfi to an 11 year old patient on January 31st 2025. This was the first dose of a Meningitis B vaccine for the patient. Patient receive Bexsero instead of MenQuafi which led to wrong vaccine administered.